EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Impact of COVID-19 Disease on Platelets and Coagulation

Geoffrey D Wool, Jonathan L Miller

Pathobiology · 2021 · 88 (1) · 15-27

DOI: 10.1159/000512007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathobiology, online erschienen am 13.10.2020. Verfasst von Geoffrey D Wool und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Chicago, Chicago, Illinois, USA, Geoffrey.Wool@uchospitals.edu. Die Arbeit wurde bisher 404-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some patients develop a severe proinflammatory state which can be associated with a unique coagulopathy and procoagulant endothelial phenotype. Initially, COVID-19 infection produces a prominent elevation of fibrinogen and D-dimer/fibrin(ogen) degradation products. This is associated with systemic hypercoagulability and frequent venous thromboembolic events. The degree of D-dimer elevation positively correlates with mortality in COVID-19 patients. COVID-19 also leads to arterial thrombotic events (including strokes and ischemic limbs) as well as microvascular thrombotic disorders (as frequently documented at autopsy in the pulmonary vascular beds). COVID-19 patients often have mild thrombocytopenia and appear to have increased platelet consumption, together with a corresponding increase in platelet production. Disseminated intravascular coagulopathy (DIC) and severe bleeding events are uncommon in COVID-19 patients. Here, we review the current state of knowledge of COVID-19 and hemostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Coagulation DisordersBlood PlateletsCOVID-19Fibrin Fibrinogen Degradation ProductsHumansSARS-CoV-2Thrombosis

Stichwörter der Autor:innen

COVID-19CoagulopathyD-dimerThrombocytopeniaThrombosis

Substanzen

Fibrin Fibrinogen Degradation Productsfibrin fragment D

Autor:innen und Institutionen

  • Department of Pathology, University of Chicago, Chicago, Illinois, USA, Geoffrey.Wool@uchospitals.edu.
  • Department of Pathology, University of Chicago, Chicago, Illinois, USA.

Zitieren

APA

Wool, G. D., & Miller, J. L. (2021). The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology, 88(1), 15-27. https://doi.org/10.1159/000512007

Vancouver

Wool GD, Miller JL. The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology. 2021;88(1):15-27. doi:10.1159/000512007

BibTeX
@article{Wool2021,
  author = {Wool, Geoffrey D and Miller, Jonathan L},
  title = {The Impact of COVID-19 Disease on Platelets and Coagulation},
  journal = {Pathobiology},
  year = {2021},
  volume = {88},
  number = {1},
  pages = {15--27},
  doi = {10.1159/000512007}
}
Kostenlos starten →